Hong Tang

TL;DR: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Infectiously Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing; The Institute of Translational Hepatology, 302 Hospital of PLA, P Beijing, China.

TL;DR: For patients who achieve virological suppression with ETV, switching to a finite course of peginterferon alfa-2a significantly increases rates of HBeAg seroconversion and HBsAg loss.

TL;DR: This review focuses on the roles and probable mechanisms of TME in HCC and shows the exosome-based immune regulation in TME to promote HCC, and summarizes the therapeutic usage of exosomes in the HCC microenvironment to provide a theoretical reference for modern antitumor agents designed to target these mechanisms.

TL;DR: Novel and important signaling molecules involved in the process of liver regeneration are reviewed to provide a cue for further research.

TL;DR: The clinical, demographic, and viral and host genetic characteristics that may influence disease manifestations and clinical management in chronic hepatitis C virus infection in China are investigated.